Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
241-255 of 3006 results
Agilent Technologies receives FDA approval for pharmDx Companion Diagnostic in NSCLC
The US Food and Drug Administration has expanded the use of Agilent Technologies' Dako PD-L1 IHC 22C3 pharmDx companion diagnostic in non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
Ortho Clinical’s automated blood analyzer gets FDA approval
By MDBR Staff Writer
ORTHO VISION Max, a fully automated blood analyzer designed by Ortho Clinical Diagnostics for high-volume transfusion medicine laboratories, has received 510(k) clearance from the US Food and Drug Administration (FDA).
Diagnostics > In Vitro Diagnostics > News
FDA approves Roche’s automated blood screening assay for use on cobas 6800/8800 systems
By MDBR Staff Writer
Roche has secured approval from the US Food and Drug Administration (FDA) for its fully automated blood screening assay for use on the cobas 6800 and 8800 systems.
Diagnostics > In Vitro Diagnostics > News
Agilent Technologies launches SureGuide CRISPR libraries for functional genomics
Agilent Technologies has launched a comprehensive offering of pooled CRISPR libraries for functional genomics.
Diagnostics > In Vitro Diagnostics > News
Sysmex Canada launches new series of hematology analyzers
By MDBR Staff Writer
Urinalysis diagnostic testing equipment provider Sysmex Canada has launched a new series of hematology analyzers.
Diagnostics > In Vitro Diagnostics > News
GeneFirst releases PCR based molecular diagnostic test
GeneFirst has launched Papilloplex HR-HPV, a PCR based molecular diagnostic test for genotyping 14 high risk human papillomaviruses from cervical and urine samples.
Diagnostics > In Vitro Diagnostics > News
3D Signatures participates in clinical trial of prostate cancer
3D Signatures has announced that its participation in a major clinical trial for prostate cancer diagnosis and management known as PRECISE.
Diagnostics > In Vitro Diagnostics > News
HiberGene launches HG Group B Streptococcus direct swab test
HiberGene Diagnostics has validated the direct testing of rectovaginal swabs with its HG Group B Streptococcus (GBS) Test, having previously launched its HG Meningococcus Direct Swab Test.
Diagnostics > In Vitro Diagnostics > News
SeraCare Life Sciences develops multiplexed cardiomyopathy reference material
SeraCare Life Sciences, a manufacturer and partner to global in vitro diagnostics manufacturers and clinical laboratories, is announcing the launch of the industry's first multiplexed reference material for inherited disease testing by next-generation sequencing (NGS) at the 2016 ASHG Annual Meeting in Vancouver.
Diagnostics > In Vitro Diagnostics > News
Sedia Biosciences, Floragenex complete merger
Healthcare firm Sedia Biosciences and biotechnology company Floragenex have announced the merger of their companies.
Diagnostics > In Vitro Diagnostics > News
Personal Genome Diagnostics to participate in US Cancer Moonshot effort to jump start liquid biopsy database
Personal Genome Diagnostics (PGDx), a leading provider of advanced cancer genome testing products and services, has announced its participation in the Blood Profiling Atlas pilot of the Cancer Moonshot initiative championed by Vice President Biden and the White House.
Diagnostics > In Vitro Diagnostics > News
FDNA, Centogene announce first grant of molecular Ttesting under Face2Gene unknown forum grant program
FDNA, developer of the Face2Gene suite of phenotyping apps, announced the successful results of its grant program to use the Face2Gene deep phenotyping and facial analysis technology to support the variant prioritization and analysis of molecular testing of patients with unknown genetic disorders.
Diagnostics > In Vitro Diagnostics > News
Qiagen unveils new solutions for liquid biopsies and hereditary diseases
Sample and assay technologies provider Qiagen has unveiled new Sample to Insight solutions for liquid biopsies and hereditary diseases.
Diagnostics > In Vitro Diagnostics > News
Episona launches epigenetic test for predicting male infertility and embryo quality
Episona, an epigenetics data company focused on improving outcomes in reproductive health, announced today the launch of Seed, an innovative new male fertility test, at the American Society for Reproductive Medicine Scientific Congress & Expo.
Diagnostics > In Vitro Diagnostics > News
Globavir announces licensing agreement with Bio-Rad for Globavir's dengue detection technology
Globavir Biosciences, a biotechnology company that develops therapeutics for infectious diseases and oncology, and diagnostics for infectious diseases, has announced a partnership with Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products.
Diagnostics > In Vitro Diagnostics > News
241-255 of 3006 results